英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

ineptly    音标拼音: [ɪn'ɛptli]
ad. 不妥当地;可笑地;笨拙地

不妥当地;可笑地;笨拙地

ineptly
adv 1: with ineptitude; in an incompetent manner; "he performed
his functions ineptly" [synonym: {ineptly}, {fecklessly}]
2: in an infelicitous manner; "this function is ineptly left to
a small voice"

Ineptly \In*ept"ly\, adv.
Unfitly; unsuitably; awkwardly.
[1913 Webster]

None of them are made foolishly or ineptly. --Dr. H.
More.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
ineptly查看　ineptly　在百度字典中的解释百度英翻中〔查看〕
ineptly查看　ineptly　在Google字典中的解释Google英翻中〔查看〕
ineptly查看　ineptly　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Libtayo: Uses, Side Effects, Warnings - Drugs. com
    Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
  • LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC, CSCC . . .
    LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI
  • Taking LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
    How will I receive LIBTAYO? LIBTAYO is a medicine prescribed by a doctor It is given in a hospital or clinic as a 30-minute intravenous (IV) infusion That means it enters the body through a vein What is the schedule for infusions of LIBTAYO? LIBTAYO is an IV infusion (350 mg) given over 30 minutes Treatment with LIBTAYO happens once every 3 weeks Infusion reactions may happen while you are
  • Libtayo (cemiplimab-rwlc): Uses, Side Effects . . . - WebMD
    Libtayo (cemiplimab-rwlc) is commonly used to treat certain types of cancer It is used to treat certain types of skin cancers, including cutaneous squamous cell carcinoma (CSCC) and basal cell
  • Squamous cell carcinoma: From symptoms to treatments
    Squamous cell carcinoma is a common type of skin cancer that often looks like a scaly patch, dome-shaped growth, or sore It tends to grow slowly, but sometimes growth is quick A board-certified dermatologist can tell you if you have this skin cancer When found early, squamous cell carcinoma is highly treatable
  • LIBTAYO® (cemiplimab-rwlc) Dosing Administration
    Review LIBTAYO® (cemiplimab-rwlc) dosing instructions with details on preparation, storage of diluted solution, and administration See Important Safety full Prescribing Information
  • Libtayo: Uses, Taking, Side Effects, Warnings - Medicine. com
    What is the most important information I should know about Libtayo? Libtayo is a medicine that may treat certain types of skin cancer by working with your immune system Libtayo can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work These problems can sometimes become severe or life-threatening and can lead to death You can
  • Cemiplimab-rwlc (intravenous route) - Side effects uses
    Cemiplimab-rwlc injection is also used to treat a type of skin cancer called basal cell carcinoma (BCC) that cannot be removed by surgery (locally advanced) or that has spread (metastatic) in patients who have received previous treatment with a hedgehog pathway inhibitor (HHI) or who cannot receive treatment with a HHI
  • LIBTAYO is a proven treatment choice in advanced CSCC
    Cemiplimab-rwlc (LIBTAYO®) is the first PD-1 inhibitor approved for adult patients with mCSCC or laCSCC who are not candidates for curative surgery or curative radiation1,4 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Squamous Cell Skin Cancer V 2 2025 recommend cemiplimab-rwlc (LIBTAYO®) as a preferred systemic therapy option for appropriate patients with advanced
  • Cemiplimab (Libtayo®) - ChemoExperts
    Treatment Name: Cemiplimab (Libtayo®) Cemiplimab (Libtayo®) is an Immunotherapy Regimen for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC) How does cemiplimab work? Cemiplimab is designed to block the signals that tumor cells use to suppress the immune system allowing the immune system to attack the lung cancer cells Goals of therapy:





中文字典-英文字典  2005-2009